Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Opioid Use Disorder Grants: Opportunities Exist to Improve Data Collection, Share Information, and Ease Reporting Burden

GAO-25-106944 Published: Dec 17, 2024. Publicly Released: Dec 17, 2024.
Jump To:

Fast Facts

Nearly 100,000 people in the U.S. died of drug overdoses from July 2023-June 2024. A vast majority of those deaths—about 75%—involved opioids.

Since FY 2018, the lead federal health agency for the opioid crisis awarded about $8.1 billion to states and $307.5 million to tribes to address it.

Grant recipients funded prevention, treatment, and other services. But:

The agency hasn't collected data on subrecipients that ultimately received funding

Some grant recipients said it was hard to find lessons learned from other successful projects

Tribes reported that administrative burdens stymied participation

Our recommendations address these issues.

Prescription pill bottles with pills falling out.

Skip to Highlights

Highlights

What GAO Found

The Opioid Response grant programs—State Opioid Response (SOR) grants and Tribal Opioid Response (TOR) grants—help address the opioid crisis by funding prevention, harm reduction, treatment, and recovery support services. SOR grants are available to states, D.C., and U.S. territories; TOR grants are available to federally recognized Tribes and tribal organizations. Since fiscal year 2018, the Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded about $8.1 billion in SOR grants and $307.5 million in TOR grants nationwide. SAMHSA allocates funding based on factors such as overdose death rates, and recently revised its allocation to better ensure funding goes to recipients with the greatest need.

State and Tribal Opioid Response Grant Funding, Fiscal Years 2018-2023

State and Tribal Opioid Response Grant Funding, Fiscal Years 2018-2023

Selected SOR recipients reported using grant funding for a variety of services, adapted to support their specific needs. States generally supported treatment for opioid use disorders, and most provided services not covered by other payers, such as transportation. Selected TOR recipients reported using funds primarily to support prevention and harm reduction efforts, such as community education.

SAMHSA collects information on proposed subrecipients, which are organizations recipients anticipate will provide grant-funded services. However, proposed subrecipients are subject to change, and SAMHSA does not collect information about the actual subrecipients once awards are made. SAMHSA officials said that collecting such information could help with efforts to improve the programs. They are determining how to address a new statutory requirement to collect and report information on the “ultimate recipients” of the Opioid Response grants. As of October 2024, the agency had not completed, documented, or implemented a plan for doing so.

SAMHSA has taken steps to address some challenges raised by grant recipients, but other challenges remain. For example, some grant recipients reported challenges obtaining data on services and results of other grant recipients. Obtaining these data would help grant recipients have additional information to use to help improve the services they offer. SAMHSA developed a data sharing strategy but has not determined specific details and time frames. Implementing such a plan would better position SAMHSA to improve how funds are used.

In addition, five tribal recipients reported that grant-related administrative challenges contribute to some Tribes not participating or not making full use of TOR. Two executive orders direct agencies to address administrative burdens for Tribes to the extent practical and permitted by law. However, SAMHSA has not assessed whether there are permissible ways under the orders to help reduce such administrative burdens, which could help to allow additional Tribes to benefit from TOR funding.

Why GAO Did This Study

The misuse of opioids has been a long-standing problem in the U.S., representing a serious risk to public health. Opioid-related overdoses accounted for about three-quarters of the estimated 96,801 drug overdose deaths in the 12-month period ending in June 2024. SAMHSA leads federal public health efforts to address the opioid crisis, including administering the Opioid Response grant programs.

The Consolidated Appropriations Act, 2023, includes a provision for GAO to review the Opioid Response grant programs. In this report, GAO examines the allocation and use of grant funds, the information SAMHSA collects on grant subrecipients, and how SAMHSA has addressed any challenges with the use of the grant funds.

GAO reviewed relevant SAMHSA funding, allocation, and other documents, and interviewed SAMHSA officials. GAO also interviewed and reviewed information from 20 grant recipients (10 states, one territory, and nine Tribes or tribal consortia) selected to reflect variation in grant funding type (state or tribal) and amount changes, overdose deaths, and geography.

Recommendations

GAO is recommending that SAMHSA (1) complete and implement a plan for reporting subrecipient information; (2) complete and implement a plan to share data about the use of grant funding; and (3) assess whether and how to reduce administrative challenges faced by Tribes and take appropriate actions. The Department of Health and Human Services concurred with our recommendations.

Recommendations for Executive Action

Agency Affected Recommendation Status
Substance Abuse and Mental Health Services Administration The Assistant Secretary for Mental Health and Substance Use should complete and implement a documented plan for collecting and reporting information about Opioid Response grant subrecipients. (Recommendation 1)
Open
HHS concurred with this recommendation. In May 2025, HHS reported that SAMHSA modifications to its existing State Opioid Response (SOR)/Tribal Opioid Response (TOR) Program Instrument tool went into effect on January 1, 2025. The modifications included the addition of a subrecipient entity inventory table to collect expenditure data for each SOR grant subrecipient in response to requirements in the Consolidated Appropriations Act, 2023 (P.L. 117-328) codified at 42 U.S.C. 290ee-3a. Grantees are to report the subrecipient information annually, with fiscal year 2025 data due by April 30, 2026. SAMHSA anticipates publicly reporting on the subrecipient data in the SOR Report to Congress in fiscal year 2026. However, HHS also stated that SAMHSA's programs, data collection, and practices are being reassessed to align with the administration's priorities and executive orders, which may affect future updates on these recommendations. We will revisit the status of this recommendation after HHS has completed its reassessment.
Substance Abuse and Mental Health Services Administration The Assistant Secretary for Mental Health and Substance Use should complete and implement a documented plan to share data or other information about the use of Opioid Response grant funding to allow grant recipients to compare their information with that of other grant recipients. (Recommendation 2)
Open
SAMHSA concurred with this recommendation. In May 2025, HHS reported that SAMHSA's Data Governance Board had met monthly from August 2024 through March 2025, to determine implementation priorities for SAMHSA's Data Strategy. The board also began to convene internal workgroups to work on solutions that would improve data access, use, and dissemination across the agency, including the SOR program. HHS also noted that SAMHSA is continuing a number of activities for SOR grant recipients to share best practices and their implementation of evidence-based practices. However, HHS did not indicate whether these efforts would result in a documented plan to share data or other information about the use of Opioid Response grant funding, as GAO recommended. In addition, HHS stated that SAMHSA's programs, data collection, and practices are being reassessed to align with the administration's priorities and executive orders, which may affect future updates on these recommendations. We will revisit the status of this recommendation after HHS has completed its reassessment.
Substance Abuse and Mental Health Services Administration The Assistant Secretary for Mental Health and Substance Use should assess options for reducing the administrative burden faced by Tribes when applying for and using Tribal Opioid Response grant funding and make changes, as appropriate, in accordance with relevant executive orders. (Recommendation 3)
Open
HHS concurred with this recommendation. In May 2025, HHS reported that SAMHSA is working to receive approval for a new Unified Client-level Performance Reporting Tool (SUPRT). This would modify the existing SAMHSA Center for Substance Abuse Treatment (CSAT) and Center for Mental Health Services (CMHS) Client-Level Performance Instruments into a streamlined, multi-component SAMHSA Client-Level Performance Tool. According to HHS, this new, streamlined client-level performance tool will help to reduce client and grantee reporting burden and enhance consistency of the collected performance data. However, HHS did not indicate whether it assessed options for reducing the administrative burden faced by Tribes when applying for Tribal Opioid Response grant funding. In addition, HHS stated that SAMHSA's programs, data collection, and practices are being reassessed to align with the administration's priorities and executive orders, which may affect future updates on these recommendations. We will revisit the status of this recommendation after HHS has completed its reassessment.

Full Report

GAO Contacts

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs

Public Inquiries

Topics

Access to health careDrug overdoseExecutive ordersGrant awardsGrant programsHealth services administrationMental healthPrescription drugsSubstance abuse